GoodRx Holdings Inc (GDRX)
NASDAQHealth CareMedical - Healthcare Information ServicesSnapshot 2026-11-05
$3.49-6.18%
Close 2026-11-05 · 1-day change
NASDAQHealth CareMedical - Healthcare Information ServicesSnapshot 2026-11-05
QuarterlyIQ Insights · GDRX
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -41.6% |
| Our one-year growth estimate | diamond |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-11-05.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| 5.6% |
Growth built into the price is above our model estimate.
The price assumes 47.2 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-05 · Compared with 9 industry peers · Company calendar date is not available
GDRX — legal / regulatory event
Dated 2026-11-02
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review On October 27, 2026, the Audit and Risk Committee of the Board of Directors (the “Board”) of GoodRx Holdings, Inc. (the “Company”), after discussion with management of the Company and the Company’s independent registered public accounting firm, KPMG LLP (“KPMG”), concluded that the Company’s condensed consolidated financial statements for the fiscal quarter and year-to-date periods end…
Why it matters: This revenue fell 26% in Q2 as active users declined and unit economics weakened. Another steep drop would deepen the pressure on total revenue.
Worry ifQ3 prescription transactions revenue falls more than 20% year over year.
Less concerning ifThe year-over-year decline is less than 10%, or revenue grows.
Why it matters: Subscription revenue grew 39% in Q2, led by condition-specific plans. Continued growth would show these plans are gaining users.
Supportive ifQ3 subscription revenue grows more than 30% year over year.
Worry ifQ3 subscription revenue grows less than 15% year over year.
Why it matters: Pharma Direct grew 76% in Q2 and is a key growth driver. Growth above 50% would show strong momentum continues.
Supportive ifQ3 Pharma Direct revenue grows more than 50% year over year.
Worry ifQ3 Pharma Direct revenue grows less than 25% year over year.
Why it matters: The report can show whether fast growth in Pharma Direct and subscriptions offsets the drop in prescription revenue.
Watch forQ3 results show total revenue growth year over year, with Pharma Direct growth above 50%.
Also watch forQ3 results show total revenue down year over year and Pharma Direct growth below 25%.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$171 on $10,000 · ±1.7% | How much price usually moves either way. |
| Bad day | $533 loss on $10,000 · 5.3% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $4,384 loss on $10,000 · 43.8% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.